Tranexamic acid for refractory gastrointestinal bleeds: A cohort study
- PMID: 28889070
- PMCID: PMC5732862
- DOI: 10.1016/j.jcrc.2017.08.035
Tranexamic acid for refractory gastrointestinal bleeds: A cohort study
Conflict of interest statement
Financial Support: None
Conflicts of Interest: Joanna L. Stollings, Janna S. Landsperger, and Matthew W. Semler have no conflicts of interest to disclose;
Figures


References
-
- Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21. - PubMed
-
- Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994;330(6):377–381. - PubMed
-
- collaborators C-t. Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–32. - PubMed
-
- Gluud LL, Klingenberg SL, Langholz SE. Systematic review: tranexamic acid for upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2008;27(9):752–758. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical